This award recognizes and celebrates exceptional achievements of individuals whose contributions have significantly influenced the field of oncology.
CRANBURY, N.J., July 18, 2023 (GLOBE NEWSWIRE) -- Targeted Oncology, a multimedia resource that offers engaging content and expert opinions on standard and emerging treatments in the field of oncology, is pleased to announce the honorees of the Oncology Icons Q2 award program. This esteemed initiative celebrates oncology clinicians who have made significant contributions in a community setting. It is designed to recognize their exceptional achievements, dedication and impact on patient care.
Through their unwavering commitment, these Oncology Icons have played a vital role in transforming the industry and improving outcomes for patients nationwide. Each nominee was assessed based on their notable achievements, innovative research and contributions to clinical practice.
“We are truly honored to recognize these exceptional individuals as icons in the field of oncology,” said Erik Lohrmann, vice president of Targeted Oncology. “These honorees not only exemplify outstanding leadership, but also serve as an inspiration for the next generation of oncology professionals.”
The Oncology Icons for Q2 2023 are:
Submissions for the Oncology Icons award program are accepted on a rolling basis throughout the year. To be eligible for the Q3 2023 award, nominations must be submitted no later than Sepember 15, 2023. To submit a nomination, please click here.
About Targeted Oncology
Targeted Oncology, a leading resource for oncologists and hematologists, empowers practice-changing outcomes through innovative learning formats and peer engagements. Its journals, Targeted Therapies in Oncology™ and Peers & Perspectives® in Oncology, are delivered 18 times a year. TargetedOnc.com offers daily content, an e-newsletter subscription, and hosts 500-plus virtual and in-person events annually, fostering engaging discussions among oncology peers. Targeted Oncology is a brand of MJH Life Sciences®, the largest privately held, independent, full-service medical media company in North America delivering trusted health care news.
MJH Life Sciences
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/bedfe1a5-3572-4433-b0f2-31fba4468e92